New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.

The Louisiana-based company offers its Ellipse Spinal Cord Stimulator Platform for treating chronic pain. The platform includes the company's patented and FDA-cleared StimuLux technology, which uses ...

First customer sites include the University of Arkansas for Medical Sciences, MUSC Health, and Calif.-based Acacia Clinics and Kaizen Brain Center BURLINGAME, Calif.--(BUSINESS WIRE)--Magnus Medical, ...

BlueWind Medical, Ltd., a leader in Implantable Tibial Neuromodulation (ITNM) and developer of the Revi® System, a ...

The International Neuromodulation Society (INS) journal Neuromodulation: Technology at the Neural Interface is publishing expert, evidence-based guidance on the safe and efficient use of ...

Samsung and Medtronic are once again teaming up, this time to build mobile tools for patients using neuromodulation therapy, a treatment used in a number of chronic conditions including chronic pain, ...

This post was co-authored by Abigail Ramos and Robert T. Muller, Ph.D. With the development of new neuro-technology and emerging research on the function of the brain, the treatment of mental illness ...

Review publication details benefits of repetitive transcranial magnetic stimulation (rTMS) on Alzheimer’s, including increases in neuroplasticity and other structural and functional second order ...

Medtech companies are increasingly investing in neuromodulation to treat UUI, which is estimated to impact 20% of adults worldwide.